Health ❯ Endocrinology

Hormones

Testosterone GLP-1 Vitamin D Metabolism Insulin Estrogen Cortisol GLP-1 Agonists Thyroid Hormones GLP-1 Receptor Agonists Leptin and Ghrelin

Tirzepatide Raises Imaging Signals of Brown Adipose Tissue in Small Randomized Trial

This could mean the drug raises calorie burning at the tissue level; confirmation will require larger trials and tissue analysis.

Early Evidence Suggests GLP‑1 Weight Drugs Can Raise Testosterone and Improve Sperm in Men With Obesity

Mouse Study Finds Removing Table Sugar From Low-Fat Diet Worsened Gut and Metabolic Health

Poor Sleep Linked to Cognitive Damage, Dementia Risk, and Higher Death Rates

Metformin’s Glucose-Lowering Power Traced to the Gut, Not the Liver

High-Resolution Map of Pancreatic Cell DNA Methylation Ties ONECUT2 to Type 2 Diabetes

VDR Gene Variant Tied to 19% Lower Diabetes Risk With High-Dose Vitamin D3

Consumer Groups Reaffirm Soy’s Safety in Moderation With Thyroid and Supplement Caveats

Keto Diet Lowers Pancreatic Stress Marker More Than Low-Fat Plan in Small Diabetes Trial

Mouse Study Finds Semaglutide Directly Reprograms Liver Cells to Ease Disease Without Weight Loss

Mexico Renews Warning as Counterfeit GLP-1 Weight-Loss Drugs Spread Worldwide

Doctor Warns GLP‑1 Weight‑Loss Shots Can Reduce Bone Density

Novo’s Triple-Hormone Obesity Drug UBT251 Hits 19.7% Mean Weight Loss in China Phase 2

Germany Reiterates Winter Vitamin D Guidance: Target Risk Groups, Not Healthy Adults

Largest Review Finds No Link Between Menopause Hormone Therapy and Dementia Risk

Study Links Longer Testis Exposure to Lower Frailty-Related Death Risk in Male Dogs

Starting Estrogen in Perimenopause Linked to Lower Cancer and Cardiovascular Risks in Massive EHR Study

Germany’s Vitamin D Guidance Shifts Toward Testing and Tailored Dosing

Timing of Menopause Hormone Therapy Linked to Divergent Alzheimer’s Risks

Menopause Review Ties Hormonal Shifts to Voice Changes, Spotlighting Risks for Voice Professionals